Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 7/20 | 0.38 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 6/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14732346 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732419 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732352 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732356 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732353 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732354 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732357 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732349 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732362 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL14732363 | 1.00 | CES2 (0.45) | CES2LPAR1LPAR3TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8999196-B2 | Liquid crystal compound having perfluoroalkyl chain, and liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-04-07 | — | — | US | disclosed |
| US-8999196-B2 | Liquid crystal compound having perfluoroalkyl chain, and liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-04-07 | — | — | US | disclosed |
| US-20130048913-A1 | LIQUID CRYSTAL COMPOUND HAVING PERFLUOROALKYL CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20130048913-A1 | LIQUID CRYSTAL COMPOUND HAVING PERFLUOROALKYL CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048913-A1 | LIQUID CRYSTAL COMPOUND HAVING PERFLUOROALKYL CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | FFAR2, RCC2, NPFFR2 | CES2 361/4885LPAR1 90/4885LPAR3 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.